Cynerio Joins Microsoft Intelligent Security Association (MISA)

NEW YORK, Sept. 12, 2024 /PRNewswire/ — Cynerio, a leading provider of healthcare-focused cybersecurity solutions, announced that they have become a part of the Microsoft Intelligent Security Association (MISA). MISA is an ecosystem of independent software vendors (ISV) and managed security service providers (MSSP). MISA members have integrated their solutions with Microsoft security technology to build a better defense against a world of increasing cybersecurity threats.

As data breaches continue to expose sensitive healthcare information, with over 118 million patients impacted in the United States in 2023, Cynerio has extended its commitment to enhancing cybersecurity in the healthcare sector, with rapid expansion globally, including 25% of NHS trusts in the UK and extensive expansion in the US and EU markets. Hospitals across the globe look to Cynerio to defend their infrastructure, medical devices, and networks, keeping thousands of patients and their data safe every day.

“As healthcare organizations across the world face increasing cyber threats and ransomware attacks, keeping patients safe and data secured has never been more important,” says Leon Lerman, CEO and Co-Founder of Cynerio. “Microsoft has long been a leader in cloud and endpoint security, and we’re thrilled to be part of MISA to better serve our customers. Our integrations with Microsoft Sentinel and Microsoft Azure are an exciting evolution that will enable customers and partners to more easily implement comprehensive, tailored solutions that protect connected medical devices and IoT in healthcare settings.”

“The Microsoft Intelligent Security Association has grown into a vibrant ecosystem of the most reliable and trusted security vendors across the globe. Our members, like Cynerio, share Microsoft’s commitment to collaboration within the cybersecurity community to improve our customers’ ability to predict, detect, and respond to security threats faster,” said Alym Rayani, Vice President, Microsoft Security

The integration between Cynerio and Microsoft Sentinel allows for customers to seamlessly execute the daily activities of collecting information, detecting threats, investigating, and responding to security incidents across healthcare environments. Furthermore, Azure customers are able to seamlessly integrate Cynerio into their cloud estates. Cynerio customers and partners can now explore integration options directly through the MISA partner catalog, providing MSP’s and customers with a more efficient way to implement healthcare-specific solutions.

The Cynerio platform contains both proactive and reactive protection measures for a multi-layered defense and centralized visibility of a hospital’s IoMT, IoT, OT, IT and mobile devices.

  • Find and remediate critical healthcare IoT risks
  • Detect and stop ransomware and breaches on healthcare IoT devices
  • Implement Healthcare IoT device micro-segmentation without impacting medical workflows
  • Activate automated mitigation and remediation for vulnerable IT devices
  • Ensure IoT security alignment between HTM, security, network, facilities, and executive teams

Partners and customers who are interested in learning more can visit the MISA Partner Catalog: Microsoft Intelligent Security Association.

About Cynerio:

Cynerio’s Healthcare Cybersecurity Platform is tailored to safeguard medical environments against constantly evolving threats. From real-time detection of malicious network activity to strategic micro-segmentation guidance, Cynerio delivers a suite of proactive and reactive protections that elevate the security of healthcare facilities and ensure the safety of patients.

Media Contact:
Name: Vicki Michaeli
Email: vicki@cynerio.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/cynerio-joins-microsoft-intelligent-security-association-misa-302245383.html

SOURCE Cynerio, Inc.

Staff

Recent Posts

BioHarvest Sciences Reports Director’s Ongoing Key Role Following Resignation from Board

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - September 20, 2024) - BioHarvest Sciences Inc. (CSE:…

13 mins ago

NervGen Pharma to Present at the Unite 2 Fight Paralysis 19th Annual Science & Advocacy Symposium Focused on Spinal Cord Injury

Vancouver, British Columbia--(Newsfile Corp. - September 20, 2024) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQB:…

13 mins ago

Water Tower Research Highlights Ainos VELDONA Clinical Trial for HIV+ Patients with Oral Warts

SAN DIEGO, CA / ACCESSWIRE / September 20, 2024 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or…

14 mins ago

Nutriband Licenses Bitrex(R) Brand Aversive Agent for Its Lead Product – Aversa(TM) Fentanyl Transdermal Patch

Nutriband signs trademark licensing agreement for Bitrex® brand denatonium benzoate, the most bitter substance in…

14 mins ago

Ipsen’s Iqirvo® (elafibranor) approved in the European Union as first new treatment for primary biliary cholangitis in nearly a decade

European Commission grants conditional marketing authorization for Iqirvo® (elafibranor), first-in-class new treatment for primary biliary…

14 mins ago

Novo Nordisk A/S: Monlunabant phase 2a trial in obesity successfully completed

Bagsværd, Denmark, 20 September 2024 – Novo Nordisk today announced headline results from a phase…

14 mins ago